Source:http://linkedlifedata.com/resource/pubmed/id/12489021
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2002-12-18
|
pubmed:abstractText |
The purpose of this study was to evaluate the markers' clinical usefulness for early prediction of recurrence, by serial and simultaneous measurements of serum cytokeratin fragment 19 (CYFRA 21-1), before and after surgery on patients with non-small cell lung cancers (NSCLC). The 48 patients enrolled in this study had adenocarcinoma of the lung (adenoCa) (including 24 patients with recurrence and 24 patients without recurrence 1 year after surgery) and 48 patients with squamous cell carcinoma of the lung (SCC) (including 24 cases with recurrence and 24 without recurrence 1 year after surgery). Serial serum levels of CYFRA 21-1 were measured before the operation and 1 week, 1 month, 3 months, 6 months, 9 months, and 12 months after surgery for the early detection of recurrence. The results revealed that (1) the mean serum values of CYFRA 21-1 were significantly higher beginning at 1 month after surgery in the 24 patients with recurrent adenoCa compared with the 24 patients without recurrent adenoCa, (2) mean serum values of CYFRA 21-1 were significantly higher beginning at 1 month after surgery in 24 patients with recurrent SCC when compared with 24 patients without recurrent SCC, and (3) mean serum values of CYFRA 21-1 were significantly higher beginning at 1 month after operation in the total 48 patients with recurrent NSCLC when compared with 48 patients without recurrent NSCLC. We conclude that CYFRA 21-1 is not a good marker for early prediction of NSCLC recurrence including adenoCa and SCC after surgery.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Keratin-19,
http://linkedlifedata.com/resource/pubmed/chemical/Keratins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/antigen CYFRA21.1
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0341-2040
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
180
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
273-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:12489021-Adenocarcinoma,
pubmed-meshheading:12489021-Adult,
pubmed-meshheading:12489021-Aged,
pubmed-meshheading:12489021-Antigens, Neoplasm,
pubmed-meshheading:12489021-Carcinoma, Squamous Cell,
pubmed-meshheading:12489021-Female,
pubmed-meshheading:12489021-Humans,
pubmed-meshheading:12489021-Keratin-19,
pubmed-meshheading:12489021-Keratins,
pubmed-meshheading:12489021-Lung Neoplasms,
pubmed-meshheading:12489021-Male,
pubmed-meshheading:12489021-Middle Aged,
pubmed-meshheading:12489021-Neoplasm Recurrence, Local,
pubmed-meshheading:12489021-Predictive Value of Tests,
pubmed-meshheading:12489021-Retrospective Studies,
pubmed-meshheading:12489021-Tumor Markers, Biological
|
pubmed:year |
2002
|
pubmed:articleTitle |
Monitoring cytokeratin fragment 19 (CYFRA 21-1) serum levels for early prediction of recurrence of adenocarcinoma and squamous cell carcinoma in the lung after surgical resection.
|
pubmed:affiliation |
Department of Thoracic Medicine, Ping Tung Christian Hospital, Ping Tung, Taiwan.
|
pubmed:publicationType |
Journal Article
|